Podcast
Dr. Gange discusses data on the UroLift System for BPH
Author(s):
The data were presented at the recent American Urological Association Annual Meeting.
In this episode, Steven Gange, MD, FACS, discusses notable data on the UroLift System for the treatment of patients with benign prostatic hyperplasia (BPH), which were presented at the 2023 American Urological Association Annual Meeting in Chicago, Illinois. Gange is a urologist at Summit Urology Group in Salt Lake City, Utah as well as an Associate Medical Director for Teleflex. He discusses the following abstracts:
- MP76-03: "Procedural Complications Associated with MIST and Invasive Surgery Compared to Disease Progression with Medical Therapy"
- PD41-06: "Pooled analysis of 330+ subjects treated with the Prostatic Urethral Lift (PUL) reveals undertreatment impacts durability"
- MP76-17: "Successful Outcomes in Acute Urinary Retention (AUR) Patients Treated with the Prostatic Urethral Lift (PUL) are Associated with Earlier Intervention"
Related Videos
Impact of Robotic Procedures and Apps on Clinic Efficiency
Amy Krambeck, MD, on innovation and building strong programs in endourology
BPH Treatment and Impact on Sexual Health
Clinical Benefits of BPH Treatments
BPH Management: Patient Outcome Evolution
Resective Surgery and Minimally Invasive Procedures For BPH
Naeem Bhojani, MD, expands on key findings from WATER III trial
Naeem Bhojani, MD, discusses WATER III data on Aquablation vs enucleation for BPH
BPH: The Patient Journey
Amy E. Krambeck, MD, on what’s needed to improve safety, efficacy of HoLEP
Related Content
